Lana E. Kandalaft, et al: Novel 2-step Immunotherapy Showed Promise for Recurrent Ovarian Cancer

Lana E. Kandalaft, et al: Novel 2-step Immunotherapy Showed Promise for Recurrent Ovarian Cancer

AACR 2013 Pressconference April 6: "Late Breaking Clinical Trials" Lana E. Kandalaft, et al: Autologous Whole-Tumor Antigen Vaccination in combination with Adoptive T cell Therapy for Patients with Recurrent Ovarian Cancer